Loading the company…
Loading the company…
Families: Dialysis access, Hernia repair.
All companies · Product and company coverage
In 2025, Atrium Medical reported engagement with 28 surgeons and other clinicians in the states MedaRep covers, worth $42K in consulting, speaking, meals and travel for its device products, the most in Virginia ($13K to 1). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Virginia ($13K, 1 engaged), Maryland ($12K, 1 engaged), Massachusetts ($9,607, 7 engaged), North Carolina ($1,115, 2 engaged), Florida ($800, 2 engaged).
In the last ten years FDA made 1 decision for Atrium Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2024 (1). The latest was on 2024-03-28.
| Family | Decisions on record |
|---|---|
| Dialysis access | 22 |
| Hernia repair | 14 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-03-28 | 510(k) | K231972 | Advanta VXT Vascular Graft, Flixene Vascular Graft |
| 2015-10-22 | 510(k) | K151386 | C-QUR, C-QUR FX, C-QUR TacShield, C-QUR V-Patch, C-QUR CentriFX, C-QUR Mosaic |
| 2015-08-27 | 510(k) | K151437 | ProLite Mesh, ProLite Ultra Mesh, ProLoop Mesh Plug |
| 2013-03-15 | 510(k) | K130142 | FLIXENE IFG VASCULAR GRAFT |
| 2012-08-17 | 510(k) |
| K122138 |
| ATRIUM FLIXENE IFG VASCULAR GRAFT |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Atrium Medical.